Publication Author: Chan_Kwun_Chuen
-
Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
Chan KC. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance. Contemp Clin Trials. 2012 Jul;33(4):786-93. Epub 2012 Mar 30.
rakerr2
-
Estimating incident population distribution from prevalent data.
Chan KC, Wang MC. Estimating incident population distribution from prevalent data. Biometrics. 2012 Jun;68(2):521-31. doi: 10.1111/j.1541-0420.2011.01708.x. Epub 2012 Feb 7.
rakerr2
-
BACKWARD ESTIMATION OF STOCHASTIC PROCESSES WITH FAILURE EVENTS AS TIME ORIGINS.
Gary Chan KC, Wang MC. Backward Estimation of Stochastic Processes with Failure Events as Time Origins. Ann Appl Stat. 2010 Sep 1;4(3):1602-1620.
rakerr2
-
p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
Tsai-Turton M, Santillan A, Lu D, Bristow RE, Chan KC, Shih IeM, Roden RB. p53 autoantibodies, cytokine levels and ovarian carcinogenesis. Gynecol Oncol. 2009 Jul;114(1):12-7. Epub 2009 Apr 26.
rakerr2
-
Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease.
Mielke MM, Kozauer NA, Chan KC, George M, Toroney J, Zerrate M, Bandeen-Roche K, Wang MC, Vanzijl P, Pekar JJ, Mori S, Lyketsos CG, Albert M. Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease. Neuroimage. 20
rakerr2
-
Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.
Lin Z, Bazzaro M, Wang MC, Chan KC, Peng S, Roden RB. Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment. Clin Cancer Res. 2009 Jan 15;15(2):570-7.
rakerr2
-
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.
Bazzaro M, Lin Z, Santillan A, Lee MK, Wang MC, Chan KC, Bristow RE, Mazitschek R, Bradner J, Roden RB. Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor. Clin Cancer Res. 20
rakerr2
-
Apolipoprotein E genotype and lifetime cognitive decline.
Kozauer NA, Mielke MM, Chan GK, Rebok GW, Lyketsos CG. Apolipoprotein E genotype and lifetime cognitive decline. Int Psychogeriatr. 2008 Feb;20(1):109-23. Epub 2007 Aug 22.
rakerr2